Evidence map›Paper›PMID 37920967›Full record

ArticleEpilepsia open2024

Association between retinal thickness and disease characteristics in adult epilepsy: A cross-sectional OCT evaluation.

Luisa Delazer, Han Bao, Michael Lauseker, Livia Stauner, Georg Nübling, Julian Conrad, Soheyl Noachtar, Joachim Havla, Elisabeth Kaufmann

Open access · goldAbstract read
In one paragraph

Article in Epilepsia open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Ocular microvascular alterations in epileptic patients.Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Luisa DelazerEpilepsy Center, Department of Neurology, LMU University Hospital, LMU Munich, Munich, Germany.ORCID 0009-0002-1330-3628
Han BaoInstitute for Medical Information Processing, Biometry, and Epidemiology, Ludwig Maximilians University, Munich, Germany.
Michael LausekerInstitute for Medical Information Processing, Biometry, and Epidemiology, Ludwig Maximilians University, Munich, Germany.
Livia StaunerEpilepsy Center, Department of Neurology, LMU University Hospital, LMU Munich, Munich, Germany.
Georg NüblingDepartment of Neurology, LMU University Hospital, LMU Munich, Munich, Germany.
Julian ConradDepartment of Neurology, LMU University Hospital, LMU Munich, Munich, Germany.
Soheyl NoachtarEpilepsy Center, Department of Neurology, LMU University Hospital, LMU Munich, Munich, Germany.ORCID 0000-0003-1314-6327
Joachim HavlaInstitute of Clinical Neuroimmunology, LMU Hospital, LMU Hospital, Ludwig Maximilians University, Munich, Germany.
Elisabeth KaufmannEpilepsy Center, Department of Neurology, LMU University Hospital, LMU Munich, Munich, Germany.ORCID 0000-0002-7582-2215
LMU Klinikum · DEZimmer Biomet (Netherlands) · NLGerman Center for Neurodegenerative Diseases · DEHeidelberg University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThinning of the peripapillary retinal nerve fiber layer (p-RNFL), as measured by optical coherence tomography (OCT), was recently introduced as a promising marker for cerebral neuronal loss in people with epilepsy (PwE). However, its clinical implication remains to be elucidated. We thus aimed to (1) systematically characterize the extent of the retinal neuroaxonal loss in a broad spectrum of unselected PwE and (2) to evaluate the main clinical determinants.

methodsIn this prospective study, a spectral-domain OCT evaluation was performed on 98 well-characterized PwE and 85 healthy controls (HCs) (18-55 years of age). All inner retinal layers and the total macula volume were assessed. Group comparisons and linear regression analyses with stepwise backward selection were performed to identify relevant clinical and demographic modulators of the retinal neuroaxonal integrity.

resultsPwE (age: 33.7 ± 10.6 years; 58.2% female) revealed a significant neuroaxonal loss across all assessed retinal layers (global pRNFL, P = 0.001, Δ = 4.24 μm; macular RNFL, P < 0.001, Δ = 0.05 mm SIGNIFICANCE: PwE presented an extensive retinal neuroaxonal loss, affecting not only the peripapillary but also macular structures. The noninvasive and economic measurement via OCT bears the potential to establish as a practical tool to inform patient management, as the extent of the retinal neuroaxonal loss reflects aspects of disease severity and sex-specific vulnerability. PLAIN LANGUAGE SUMMARY: The retina is an extension of the brain and closely connected to it. Thus, cerebral alterations like atrophy reflect also on the retinal level. This is advantageous, as the retina is easily accessible and measureable with help of the optical coherence tomography. Here we report that adults with epilepsy have a significantly thinner retina than healthy persons. Especially people with many big seizures and a lot of medications have a thinner retina. We propose that measurement of the retina can be useful as a marker of disease severity and to inform patient management.

Indexed as

EpilepsyRetinal Ganglion CellsAdultCross-Sectional StudiesFemaleHumansMaleProspective StudiesRetinaTomography, Optical CoherenceYoung Adultanti-seizure medicationbrain atrophydisease burdenfocal to bilateral tonic clonic seizuresoptical coherence tomographysexual dimorphism

Identifiers

PMID37920967
PMCPMC10839337
OpenAlexW4388296083

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.